Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 43.10% is in line with its 5-year average of 42.34%, around the middle of its 5-year range (31.59%–61.57%).
2.01% above its 12-month average of 42.25%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 34.48%.
OPERATING MARGIN
43.10%
OPERATING MARGIN AVG TTM
42.25%
OPERATING MARGIN AVG 3Y
42.25%
OPERATING MARGIN AVG 5Y
42.34%
OPERATING MARGIN AVG 10Y
42.69%
OPERATING MARGIN AVG 15Y
41.59%
OPERATING MARGIN AVG 20Y
38.63%
CURRENT VS TTM AVG
+2.01%
CURRENT VS 3Y AVG
+2.02%
CURRENT VS 5Y AVG
+1.79%
CURRENT VS 10Y AVG
+0.95%
CURRENT VS 15Y AVG
+3.64%
CURRENT VS 20Y AVG
+11.56%
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+189.26%
vs the sector median at left
Novo Nordisk A/S
Market Cap
$185.26B
Operating Margin
43.10%
TTM Avg
42.25%
3Y Avg
42.25%
5Y Avg
42.34%
Market Cap
$183.36B
Operating Margin
39.74%
TTM Avg
22.76%
3Y Avg
25.11%
5Y Avg
25.54%
Market Cap
$177.12B
Operating Margin
17.03%
TTM Avg
17.21%
3Y Avg
17.41%
5Y Avg
17.71%
Market Cap
$146.59B
Operating Margin
20.42%
TTM Avg
21.31%
3Y Avg
23.25%
5Y Avg
23.28%
Market Cap
$135.05B
Operating Margin
31.28%
TTM Avg
28.70%
3Y Avg
26.89%
5Y Avg
27.25%
Market Cap
$130.27B
Operating Margin
38.59%
TTM Avg
18.66%
3Y Avg
31.09%
5Y Avg
34.52%
Market Cap
$129.92B
Operating Margin
28.27%
TTM Avg
24.24%
3Y Avg
21.84%
5Y Avg
19.75%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novo Nordisk A/S (NVO) | $185.26B | 43.10% | 42.25% | 42.25% | 42.34% |
| Gilead Sciences, Inc. (GILD)vs › | $183.36B | 39.74% | 22.76% | 25.11% | 25.54% |
| Abbott Laboratories (ABT)vs › | $177.12B | 17.03% | 17.21% | 17.41% | 17.71% |
| Amgen Inc. (AMGN)vs › | $203.12B | 33.18% | 25.38% | 28.78% | 30.08% |
| Pfizer Inc. (PFE)vs › | $156.51B | 25.08% | 25.29% | 24.23% | 24.05% |
| Danaher Corporation (DHR)vs › | $146.59B | 20.42% | 21.31% | 23.25% | 23.28% |
| Intuitive Surgical, Inc. (ISRG)vs › | $135.05B | 31.28% | 28.70% | 26.89% | 27.25% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.27B | 38.59% | 18.66% | 31.09% | 34.52% |
| Bristol-Myers Squibb Company (BMY)vs › | $129.92B | 28.27% | 24.24% | 21.84% | 19.75% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $240.97B | 17.69% | 18.04% | 18.11% | 20.54% |
Gross Margin
80.6%
Operating Margin
43.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 34.48% |
| 2026-03-31 | 61.57% |
| 2025-12-31 | 40.10% |
| 2025-09-30 | 31.59% |
| 2025-06-30 | 43.52% |
| 2025-03-31 | 49.68% |
| 2024-12-31 | 42.88% |
| 2024-09-30 | 47.43% |
| 2024-06-30 | 38.10% |
| 2024-03-31 | 48.73% |
| 2023-12-31 | 40.64% |
| 2023-09-30 | 45.82% |
| 2023-06-30 | 43.99% |
| 2023-03-31 | 46.86% |
| 2022-12-31 | 35.53% |
| 2022-09-30 | 44.30% |
| 2022-06-30 | 44.57% |
| 2022-03-31 | 45.55% |
| 2021-12-31 | 35.57% |
| 2021-09-30 | 42.81% |
| 2021-06-30 | 44.73% |
| 2021-03-31 | 44.32% |
| 2020-12-31 | 34.78% |
| 2020-09-30 | 41.41% |
| 2020-06-30 | 46.12% |
| 2020-03-31 | 48.12% |
| 2019-12-31 | 36.63% |
| 2019-09-30 | 42.67% |
| 2019-06-30 | 44.79% |
| 2019-03-31 | 48.61% |
| 2018-12-31 | 36.27% |
| 2018-09-30 | 42.55% |
| 2018-06-30 | 44.53% |
| 2018-03-31 | 46.22% |
| 2017-12-31 | 35.89% |
| 2017-09-30 | 45.25% |
| 2017-06-30 | 46.74% |
| 2017-03-31 | 47.41% |
| 2016-12-31 | 37.89% |
| 2016-09-30 | 45.10% |
| 2016-06-30 | 45.51% |
| 2016-03-31 | 45.23% |
| 2015-12-31 | 38.53% |
| 2015-09-30 | 44.71% |
| 2015-06-30 | 46.13% |
| 2015-03-31 | 54.99% |
| 2014-12-31 | 37.25% |
| 2014-09-30 | 38.51% |
| 2014-06-30 | 40.38% |
| 2014-03-31 | 39.49% |
| 2013-12-31 | 33.89% |
| 2013-09-30 | 38.96% |
| 2013-06-30 | 40.15% |
| 2013-03-31 | 37.84% |
| 2012-12-31 | 36.12% |
| 2012-09-30 | 39.63% |
| 2012-06-30 | 39.31% |
| 2012-03-31 | 35.97% |
| 2011-12-31 | 33.56% |
| 2011-09-30 | 33.93% |
| 2011-06-30 | 32.90% |
| 2011-03-31 | 34.52% |
| 2010-12-31 | 26.94% |
| 2010-09-30 | 32.88% |
| 2010-06-30 | 32.75% |
| 2010-03-31 | 32.05% |
| 2009-12-31 | 24.64% |
| 2009-09-30 | 30.47% |
| 2009-06-30 | 31.46% |
| 2009-03-31 | 30.48% |
| 2008-12-31 | 26.83% |
| 2008-09-30 | 29.56% |
| 2008-06-30 | 25.63% |
| 2008-03-31 | 26.65% |
| 2007-12-31 | 10.36% |
| 2007-09-30 | 25.52% |
| 2007-06-30 | 26.60% |
| 2007-03-31 | 23.71% |
| 2006-12-31 | 20.06% |
| 2006-09-30 | 26.13% |
| 2006-06-30 | 27.05% |
| 2006-03-31 | 21.05% |
| 2005-12-31 | 20.39% |
| 2005-09-30 | 26.25% |
| 2005-06-30 | 28.27% |
| 2005-03-31 | 20.81% |
| 2004-12-31 | 22.94% |
| 2004-09-30 | 23.62% |
| 2004-06-30 | 26.28% |
| 2004-03-31 | 23.06% |
| 2003-12-31 | 25.13% |
| 2003-09-30 | 24.38% |
| 2003-06-30 | 24.80% |
| 2003-03-31 | 21.65% |
| 2002-12-31 | -187.05% |
| 2002-09-30 | 100.00% |
